Drug intelligence / Profile preview

ethinylestradiol + cyproterone acetate

Development stage
Phase 4
Lead developer
Bayer
Modality
Small Molecules
Administration
Oral
01

Overview

ethinylestradiol + cyproterone acetate is a combined oral contraceptive pill frequently used in the management of polycystic ovary syndrome (PCOS). It consists of ethinylestradiol, a synthetic estrogen, and cyproterone acetate, a synthetic progestogen with potent anti-androgenic activity. The combination works by suppressing the secretion of pituitary gonadotropins, thereby inhibiting ovarian androgen production, while the cyproterone component directly blocks androgen receptors in target tissues. This dual action effectively treats clinical manifestations of hyperandrogenism, such as acne and hirsutism, and regulates menstrual cycles in women with PCOS. Chongqing Medical University has conducted comparative clinical trials evaluating its efficacy against metformin regarding insulin sensitivity and ovulation.

Brand names
Diane-35Diane35Diane 35DianetteGinetteEstelle
Other names
Cyproterone acetate/ethinylestradiolEE/CPA
02

Targets

AR (Adrenergic receptors)ER (Estrogen receptor)PR (Progesterone receptor)

Beyond the preview

Go deeper on ethinylestradiol + cyproterone acetate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ethinylestradiol + cyproterone acetate.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call